ClinicalTrials.govpublic full text
Using Machine Learning to Identify Responders to TACE or HAIC for uHCC
unresectable hepatocellular carcinoma (hcc), bclc stage b hepatocellular carcinoma, bclc stage c hepatocellular carcinoma, hepatocellular carcinoma, transarterial chemoembolization, hepatic arterial infusion chemotherapy, machine learning, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 873517
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.